8 resultater
The present invention relates to vitamin D derivatives Formula (I): ##STR2## where R.sub.1, R.sub.2 and R.sub.3 which may be the same or different each represents a hydrogen atom or a hydroxyl group; X is an oxygen atom, the group of the formula OR.sub.4 (where R.sub.4 is either a hydrogen atom or a
TECHNICAL FIELD
The present invention relates to a screening method for drugs using a 67 kDa laminin receptor, and to a drug obtained by it.
BACKGROUND ART
67 kDa laminin receptor (hereinafter it may be referred to as "67LR") is a protein of 67 kDa, which is derived from a 37 kDa precursor protein
FIELD OF INVENTION
This invention relates to the use of lunasin and other selected cytokines in conjunction with their broad application over innate immune system responses. Particularly, lunasin demonstrated robust synergy on certain selected cytokine effect on innate immune cells.
BACKGROUND
The
FIELD OF THE INVENTION
The present invention relates to physiologically active substances which are extracted from a tissue or cells activated by internal and external stressors, and to methods for producing the physiologically active substances. The present invention also relates to pharmaceutical
FIELD OF THE INVENTION
The present invention relates to a method for imparting pharmacological activities to immunoglobulin such as eosinophilia-suppressive action, immunomodulating action, therapeutic action for autoimmune disease, antiinflammatory action, antiallergic action, etc. which are not
FIELD OF THE INVENTION
The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of
FIELD OF THE INVENTION
The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel water soluble extract from nonpathogenic aerobic corynebacteria. More particularly, the invention relates to a water soluble extract from nonpathogenic aerobic bacteria, the said extract having the following